Bringing medical research to the front line with new discoveries with Alpha1 Antitrypsin.
The Mark Egly Foundation has become dedicated to the world's education on many diseases and the prevention and treatment of multiple diseases and conditions. Mark's discovery of his Alpha1 Antitrypsin Deficiency led him to find many other related conditions previously not associated with Alpha1 Antitrypsin and its deficiency.
The MEF is now leading the fight for individuals who need appropriate treatment much earlier in life before the manifestations of hundreds of previously unknown health ailments associated with Alpha1 Antitrypsin and its deficiency! We have started educating medical professionals from almost every medical field and the public about Alpha1 Antitrypsin on our medical discoveries that relate to many medical conditions and situations previously not thought to be related to the Alpha1 Antitrypsin protein!
With our promise, we will continue to educate the world of medicine that Alpha1 Antitrypsin Deficiency does not only affect the liver and the lungs of those with the disease! Alpha1 Antitrypsin Deficiency is a deficiency of a single protein. The deficiency and sometimes improper protein unfolding can cause mild to severe illnesses. The leading cause for AATD can be related to the varying types of alleles of the SERPINA1 gene. Today, through Mark's research and discoveries, we know that we can prevent and treat a significant number of conditions well beyond liver and lung disease!
Because of Mark Egly's passion for the last 45 years to discovering why many of his family members died way too early in life from so many different cancers and maladies! Breast cancer, lung cancer, prostate cancer, ovarian cancer, stomach cancer, and so much more have taken so many aunts, uncles, grandparents, great grandparents, great uncles, great aunts, cousins, and babies long before living life to their fullest!
Lung issues have been at the forefront of many individuals' health issues in his family. In 2018, after suffering breathing problems for decades, Mark was found to have COPD and emphysema. As a well-conditioned professional athlete and a lifetime non-smoker, the diagnosis did not fit Mark and his healthy lifestyle.
From the diagnosis of COPD and emphysema, Mark came up with a diagnosis in less than five days of continued research. Mark requested doctors to test him for a disease that had only been found in approximately 8,000 people ever at that time in 2018, Alpha1 Antitrypsin Deficiency.
Mark's continued research has found that single reason for many of Mark's and his own family's health issues throughout their family's history. Mark's research led to a US Patent filing in 2020, METHOD OF PREVENTING AND/OR TREATING A PLURALITY OF DISEASES. With the discoveries within that patent filing, we hope to assist other families across the world find better health and avoiding the horrors of cancer and so many other diseases. These diseases can potentially be avoided and/or treated with Mark's discoveries by educating medical professionals and the public through the work of the Mark Egly Foundation.
Please join our pursuit of a healthier world.